Alphatec Holdings, Inc. (ATEC)
Nasdaq · Healthcare · Medical Devices
$10.72+6.88%as of Oct 6, 2026, 1:35 AM ET
- Market cap
- $1.7B
- Forward P/E
- 17.9
- 52-week range
- $6.82 – $23.29
- 52-week change
- −26.25%
- EPS (trailing)
- −$0.72
- Next earnings
- Oct 29, 2026
Fiscal year to Dec 2025
- Revenue
- $764M (+24.95%)
- Net income
- −$143M
- Operating margin
- −10.7%
- Diluted EPS
- −$0.96
- Free cash flow
- $2.8M
From the company’s annual report on SEC EDGAR.
About Alphatec Holdings, Inc.
Alphatec Holdings, Inc., a medical technology company, designs, develops, and advances technologies for the surgical treatment of spinal disorders in the United States and internationally. The company manufactures and sells implants, instruments, imaging equipment, and spare parts. It offers Alpha InformatiX product platform, including EOS imaging system that provides full-body imaging; SafeOp Neural InformatiX System that automates electromyographic, somatosensory evoked potential, and motor evoked potential monitoring; and Valence, an intra-operative system that integrates navigation and robotics into spine procedures, as well as Sigma Prone TransPsoas (PTP) Access and PTP Patient Positioning Systems. It also provides split-blade retractors; Sigma-ALIF Access System, a procedure-specific access system; spinal implants and fixation systems comprising NanoTec and Invictus, as well as various standalone implants for height restoration and stabilization.
Headquarters: Carlsbad, United States · 913 employees · atecspine.com